Pfizer and Eisai voice "serious concerns" following NICE Alzheimer's review
12 June 2009
Becky Debens
The model used by the UK's
National Institute for health and Clinical Excellence (NICE) to decide if certain drugs should be used to treat mild stage Alzheimer's disease contains "significant errors",
Pfizer and
Eisai have claimed.
NICE announced yesterday that its 2006 decision that four dementia...
Please Login to read the full article.
12 June 2009
Becky Debens
NICE announced yesterday that its 2006 decision that four dementia...
Please Login to read the full article.
RELATED CONTENT
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
